Eosinophils do respond to FMLP
Descrição do Produto
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
1987 70: 379-383
Eosinophils do respond to fMLP M Yazdanbakhsh, CM Eckmann, L Koenderman, AJ Verhoeven and D Roos
Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
Eosinophils By
Maria
Yazdanbakhsh,
Carel
M.
Do Respond
Eckmann,
Leo
to fMLP
Koenderman,
Arthur
Eosinophils were isolated from normal human blood by separation over Percoll gradients, which resulted in eosinophil suspensions of a purity higher than 95% and recoveries of about 65%. Normal human eosinophils were found to respond to formyl-methionyl-leucyl-phenylalanine (fMLP)
fMLP
as was
tions
(iO8
of
another
at
treatment
of
concentrations
>iO
mol/L
with
an
increase
in
the
concentration of intracellular free calcium, oxygen consumption, nitroblue tetrazolium reduction, and chemiluminescence. The maximal response of eosinophils to fMLP was lower than that of neutrophils isolated from the same blood samples and required at least ten times as much
D
IFFICULTIES human
Most
studies
tial
have
these
eosinophils
hampered
so far have
eosinophilia; normal isolation
in obtaining
blood
used
are
responsiveness
of eosinophils
and
to this to fMLP
mol/L. patients
However, previous studies with eosinophilia have shown
these
report, in the
as well
cells.
we
with
In addition,
and
have
dismutase
Molecular
Biochemicals,
ries,
Alderley
sulfoxide
incubations (10
and stored
.tg/mL)
had
erythrocytes,
City,
of
lucigenin
and Fura-2
OR).
cytochalasin
NBT were was bought
Digitonin
B (ICI
UK)
1,000
was
times
were
the
Research
dissolved
final
for
cell
of DMSO
on the cells.
Percoll. Percoll suspensions (Pharmacia Fine Chemicals, Uppsala, Sweden) were prepared with specific gravities of 1 .077, 1.082, and 1.084 g/mL at room temperature. The specific gravities were measured with a density meter (Anton Paar, Graz, Austria, model DMA 46). The osmotic value of all Percoll suspensions was 290 mosm
The NaCI,
(measured
with
incubation 2.7 mmol/L
I .0 mmol/L
MgC12,
a semi-Osmometer,
medium KCI,
Knauer,
for the cells 8.1 mmol/L
5.5 mmol/L
consisted
Na2HPO4, glucose,
and
albumin.
Blood,
Berlin,
FRG).
of I 38 mmol/L 0.6 mmol/L
0.5%
(wt/vol)
S
1987
by Grune
of
fMLP
ability
to
eosinophils
eosinophils
showed respond
be
used
to to
to
after
that
do respond
not
stimulate neutrophils. concentrathese
fMLP.
We
fMLP
and
isolate
eosino-
& Stratton,
Inc.
preparation. Blood was obtained from healthy volunteers 3% to 8% eosinophils in their peripheral blood. Granulocytes were purified from the buffy coat of 500 mL of blood anticoagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4). The buffy coat was diluted three times with phosphate-buffered saline (PBS) containing 13 mmol/L trisodium citrate (PBS-citrate) and centrifuged (20 minutes, 1,000 g, room temperature) over Percoll with a specific gravity of 1.077 g/mL. The erythrocytes in the pellet fraction were lysed with isotonic ammonium chloride at 4#{176}C as described.’ The granulocytes were subsequently incubated for 30 minutes at 37#{176}C in Hanks’
buffered
(vol/vol)
fetal
I .084
salt calf
solution
serum
with
(pH
7.0
20 at
mmol/L
g/mL.
This
suspension
was
HEPES
37#{176}C),to restore
gravity of the cells. Thereafter, in Percoll with a specific gravity layered
and the
5%
original
the granulocytes were at room temperature of on
top
of Percoll
with
a
of 1.1 g/mL and overlaid with 0.2 mL PBS. The tubes were centrifuged for 20 minutes at I .000 g at room temperature. Neutrophils (>98% pure) from the upper interface were collected, washed in PBS-citrate, and resuspended in incubation medium. The cells from the lower interface were also washed and gravity
resuspended
in the
incubation
medium;
the
resulting
cell
suspension
represented a 50% to 70% recovery of the eosinophils present in the buffy coat, at more than 95% purity. The contaminating cells were neutrophils. Eosinophils were also isolated as described by Roberts and Gallin.3 Briefly, whole blood was anticoagulated with EDTA (final concentration, 0.3%, wt/vol). Prewarmed blood was incubated with IMLP (l06 mol/L) for 15 minutes at 37#{176}C.Thereafter, it was layered over Percoll with a specific gravity of I .082 g/mL and centrifuged (25 minutes, 400 g, room temperature). Erythrocytes and eosinophils constituted the layer below the Percoll. The erythro-
From Blood
the
CaCl2, human
Central
Transfusion
Clinical
in dimethyl
concentration
eosinophils or to a suboptimal with
should
concentra-
not
pur-
Laborato-
at -70#{176}C.The final concentration
no effect
reduc-
FRG). Phorbol myristate acetate Corp. Katonah, NY), fMLP (Vega
Cheshire, at
to
METHODS
bovine
(Junction
and
Park,
(DMSO)
(NBT)
dinitrate), Co (St Louis).
(Darmstadt, Midland
Tucson),
report, able
properties.
AND from
Probes
from Merck Consolidated
individ-
also
their
fMLP
fMLP did
Purification
blood
lost
therefore
specific
free calcium,
tetrazolium
altered
(l0,lO’-dimethyl-9,9’-biacridinium obtained from Sigma Chemical from
are
by
opsonized of the
In the present
either respond
normal
Low
phils.
suspended
In addition, we demonstrate with fMLP by the method
MATERIALS
chased (PMA;
normal
in intracellular
nitroblue
Gallin3
Superoxide
from
that
Roos
in themselves
stimulus. whole
had
conclude
specific
metab-
generation
response to by pretreatment
eosinophils
by an increase
consumption,
oxygen
(LTC4)
of fMLP.7 human
and chemiluminescence. eosinophils isolated
Roberts
C4
in eosinophils
normal
to fMLP
oxygen tion, that
that
Acdo not to l06
on eosinophils from that fMLP enhances
stimulates
of LTC4 in to be augmented
low concentrations
show
respond
and
as leukotriene
uals, the generation particles was shown cells
of
to formyl-
normal human eosinophils concentration range of l0
of Fe receptors
release
with
those
was described.
eosinophils
neutrophils.
which
by cells to
Dirk
Cell
patients from
consumption primed these
that
for
and
with
cells.
neutrophils
(fMLP)
cording respond
olite
from
different
normal
these
In a recent report,3 a method for the human eosinophils based on the differen-
methionyl-leucyl-phenylalanine
the expression
from with
eosinophils
eosinophils
individuals.”2 of normal
studies
needed mol/L).
#{176}2
tion
J. Verhoeven,
Immunology,
Submitted
July
Supported
by
Address
Netherlands for
to
March
Dirk
Laboratory Service,
Cross and
of Amsterdam. 900-512-057
requests
Red
Experimental
20. 1987. of
the
(FUNGO). which is subsidized the Advancement ofPure
Central
Transfusion
No.
the
Laboratory
10. 1 986; accepted Grant
reprint
Secretariat,
of
and
University
Medical Research lands Organizationfor
Blood
Laboratory Service
P0
of Box
Roos. the
Foundation
PhD.
do
Publication
Netherlands
9406.
for
by the NetherResearch (ZWO).
1006
Red
AK
Cross
Amsterdam,
The Netherlands. The publication charge
payment.
“advertisement” indicate
costs
ofthis
article
This
article
must
in accordance
with
were defrayed therefore /8
U.S.C.
in part
be hereby §1734
by page marked solely
to
this fact.
1 987 by Grune
& Stratton.
Inc.
0006-4971-87-7002-0006$3.OO/O
Vol 70, No 2 (August),
1987:
pp 379-383
379
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
YAZDANBAKHSH
380
cytes were lysed with the previous paragraph. 90%,
with
recoveries
Metabolic an
isotonic ammonium chloride The purity of eosinophils of 70%
oxygen
to 90%.
Oxygen
reactions. electrode
as
as described in was higher than
consumption
described
was measured
before.9
NBT
with
reduction
was
measured by incubating cells for 30 minutes at 37#{176}C with NBT (500 sg/mL) in the presence or absence of stimuli. At the end of the incubation, the cells were fixed with paraformaldehyde (final concentration, 1%, vol/vol) and spun on a glass slide with a cytospin centrifuge. Thereafter, the slides were stained with nuclear fast red (0.1%, wt/vol), and the percentage of NBT-positive cells was scored as described before.’#{176}One cell sample was stained with MayGrtinwald/Giemsa
and
used
for
the
determination
of
the
Lucigenin-enhanced chemiluminescence was determined as follows: Minivials were filled with 1 mL of cell suspensions (10 cells/mL). The vials were placed in polyethylene counting vials in a scintillation spectrometer with a controlled temperature of 37#{176}C (Packard
Tricarb
started
by the
3310,
addition
Downers
Grove,
1 mL
of prewarmed
of
lucigenin (640 zmol/L) continuously for ten minutes of the apparatus. Where indicated, cytochalasin B (10 sg/mL) for three counted
of cytosolic
neutrophils.
pended mmol/L
Mg504,
mmol/L
potassium
(wt/vol)
by incubation
warm 40
albumin
1 zmol/L
HEPES
DMSO. pended
After
The
were
with
the loading
and
in HEPES
continued
as
that
found
in
analysis was performed test for paired observations.
with
Statistical t
RESULTS Oxygen
consumption.
sponded
to fMLP
The
response
about
l0
for
the
Normal
by a rapid
was
dose
mol/L
reaction
(Fig
cytochalasin fMLP.’5 response
1).
It
with
that was
optimal
was has
been
the
a maximum
shown
these
cells
cytochalasin
B. This
on the 02 consumption
of either
and
that
shown
previously
response
effect
mol/L,
twice of
the 02 consumption also augmented
the by that
neutrophils
to
by eosinophils by pretreatment
agent
by
cell type.
itself
had
in of no
Cytochalasin
B augmented the fMLP-stimulated neutrophil respiration 100% to 200%, whereas that of eosinophils was enhanced
02
at
concentration
106 was
re-
consumption.
fMLP
about
response
B enhances We found to fMLP
in oxygen reaching
The
of the maximal
eosinophils
human
increase
dependent,
fMLP.
neutrophil
magnitude
by by
to 60%. at
a concentration
consumption
priming in
same
of
I0_8
by eosinophils;
these
cells
fMLP
(10_8
tion
in response
mol/L)
(Table for
1 ). two
mol/L
however, Eosinophils
minutes
to a suboptimal
showed
concentration
did
not
it was
stimulate
capable
pretreated an
of with
02 consumpof PMA (0.5
(vol/vol)
use.
oxygen
resus-
Prior
consumption
to each
( 10 cells/ concentration, 106
or neutrophils
medium
at 37#{176}C for
analysis.
test or Student’s
t
the
cells.’4
for a further 0.1%
on ice before
incu-
with the
the cells were washed,
kept
of
stock
five times
with
eosinophils
incubated
cuvette. Fluorescence
was
procedure,
medium,
diluted and
l-mmol/L
incubated
Statistical
fMLP
ester
is approximately
ie, 0.35 jzL/106
Student’s
30%
0.5%
were
of eosinophils
neutrophils,
Fura-2”
methyl
cells/mL) a
1.2
and
loaded
(l0
(from
were
Fura-2-loaded
were
cells
incubation
cells
in HEPES
cells/mL)
Cells
content
eosinophils
and
HEPES,
glucose,
at 37#{176}C and then diluted
Control
measurement,
mL)
7.4)).
eosinophils
mmol/L
mmol/L
Fura-2/AM
medium.
minutes.
medium
were washed and susNaCl, 6 mmol/L KCI, I 20
5.5
Prewarmed
for 20 minutes
was
incubation
in human
CaCl2,
(pH
reaction
of the cells at 37#{176}C with the acetoxy
with
DMSO)
(132
phosphate,
(Fura-2/AM).
bated
Ca2
neutrophils mmol/L
and
medium 1 mmol/L
human
Fura-2
free
Eosinophils
in HEPES
The
and a stimulus. Each vial was in the out-of-coincidence mode cells were preincubated with minutes at 37#{176}C.
containing
Measurement
IL).
the fluorescence after digitonin addition, and Fmj. 5 the fluorescence after Mn2 quenching. Agonists used gave no autofluorescence changes in unloaded control cells. Fura-2 contents in the cells were determined by adding Fura2-free acid to the cell suspensions. On average, the Fura-2 content of the cells was 1 10 smol/L, under the assumption that the free water
cell
composition.
ET AL
(final
1 5 minutes
before
performed
with
transfer
to a U)
measurements
were
a spectrofluo-
5) U
rometer
(model
contents
of the
holder was wavelengths Fura-2
RF-540, cuvette
Shimadzu were
Corp.
magnetically
Kyoto, stirred,
iapan). and
thermostated at 37#{176}C. The excitation were 335 nm and 505 nm, respectively.”
fluorescence
as a function
of [Ca2]i
was
The
the
)00
cuvette
and emission Calibration of
determined
0
0
essen-
E C
as described for Quin-2 fluorescence’2”3 with the following modifications. To saturate all trapped Fura-2 with Ca2, 5 ,mol/L digitonin was added to the cell suspension. At this digitonin concentration, the cell membrane was found to be permeable for small solutes without causing lysis of the cells, thereby avoiding a dramatic tially
shift
in
autofluorescence.
quenched
by adding
MnCl2)
Subsequently, 0.5
mmol/L
to the cell suspension.
Ca2-independent
fluorescence
Mn2t
The percentage
found
to be 36%
Cytosolic
the Ca2-dependent
where
224
224
nmol/L
were
Fura-2
Fura-2
was
mmol/L
and
the
by addition
fluorescence quenched
of
by Mn2.
the
Fura-2/Ca2
Fig 1 . Oxygen consumption by eosinophils (--) and neutrophils in response to various fMLP concentrations. The results show the maximum amount of oxygen consumed by cells stimulated with fMLP (usually three to four minutes after stimulation). The amount of oxygen consumed by cells at rest has already been subtracted. Each point represents the mean ± SEM of (n) experiments. (-)
+0.36[F F
[fMLrjM
was
as follows:
nmol/L
K4 for
of0.5
quenched
fluorescence
was calculated
is the
a stock
signal
Both signals
F-(F. [Ca2]
Fura-2
(from
ofCa2-independent
of the total
free Ca2
the
Mn2
-F.]) -F complex,”
Fma. is
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
EOSINOPHIL
RESPONSE
381
TO FMLP
Table
1 . Priming
Effect
chemiluminescence
of fMLP C.,
Oxygen Consumption (nmol 02/10’ cells/mm)
Test Condition PBS
Eosinophils
Lag time
12
(Mini
Neutrophils
Eosinophils
Neutrophils
0.6
8.4
6.5
5)
pretreat-
ment fMLP
+
PMA
(10’
1.6
0.3
±
±
0.2
2.0
±
±
1
0.3
E
mol/L)
pretreatment
+
PMA
8.6
1.4
±
3.0
±
0.4
5.4
1.3
±
3.3
±
0.3
Oxygen consumption by eosinophils and neutrophils in response to PMA (0.5 for eosinophils and 1 .0 ng/mL for neutrophils) is shown. The cells were preincubated with either PBS fMLP (10’ mol/L) for two minutes before the addition of PMA. fMLP by itself did not stimulate either cell type. The lag time is the time after the addition of PMA. before maximum velocity is reached, as defined by Cohen and Chovafliec.” All results are expressed as means ± SEM of three experiments. The differences between PBS- and fMLP- (10’ mol/L)-treated cells were all significant at P < .05 using Student’s t test for paired observations.
ng/mL
8
4
ng/mL)
with
a shorter
velocity
than
control
results
were
tions tion
obtained
of PMA
compared used
more
reduced
neutrophils.
NBT.
hence had
When 95% The
the
tg/mL)
before
increased the percentage NBT from 1% to 19% NBT
Cytochalasin by either
with
fMLP
82%.
and
was
no priming
I ng/mL.
effect.
with
PMA and
(0.1 eosinophils
of fMLP cytochalasin
l0
mol/L
of eosinophils capable that of neutrophils
is B
fMLP
of reducing from 21% to
B alone did not stimulate the reduction of cell type. When the eosinophils were primed
(l0
mol/L)
of formazan-positive ng/mL) increased
from
for three
minutes,
the
eosinophils in response 50% to 90%.
Lucigenin-enhanced
percentage to PMA
chemiluminescence.
to fMLP by a rapid increase in chemiluminespeaked at about one to two minutes and reached
value
8.9
±
1.4
x
I0
cpm
(25
(mean
±
SEM
of
experiments). second
slide
peak
that
reached
(mean
minutes.
a nine
eosinophil
small
peak
cpm
±
SEM
Figure
3A
with
to fMLP
fMLP
was enhanced is an oxygen-dependent
not
necessarily
dase
activity,
correlate evident
affect
itself.
with from
and a reaction
Cytosolicfree
4)
U,
0
a N
0
io
io
io
[fMLP] NBT reduction by eosinophils (--) to various concentrations of fMLP. ± SEM of three experiments
and neutrophils (-I Each point represents
in
metabo-
effect
on
levels
in eosinophils
free
and neutrophils Fura-2. The
fMLP, rose
the intracellular
to values
10_6 mol/L intracellular nmol/L (mean (Fig 4). When
neutrophils
93 ± 6 nmol/L of n experiments).
fMLP Ca2
of more
calcium
concen-
were change
also induced concentration,
± SEM, eosinophils
n
was (n = Upon
Ca2 than
the
or neutrophils. measured in Fura-2
and
phils
(M)
oxygen no
of
cytochalasin
Ca2
mol/L
icc8
the
had
oxi-
kinetics
after the addition of fMLP change in Quin-2 fluorescence by Pozzan et al.’3 The resting
(n = 9) and (mean ± SEM
0
the
fluorescence in neutrophils was similar to the neutrophils as observed
4)
E
of the
in
from
Intracellular
Ca2.
the
cytochalasin B. process but does
Thus,
eosinophils
trations in both eosinophils with the fluorescent indicator
unlike
parameters
B alone
of either
decreased
assay,
difference
distinct
l0 ten
of eosinophil one
by
02 consumption.
Cytochalasin
x
around
was inhibited by cytoneutrophil chemilumi-
other
the
peak
in this
with Chemiluminescence
2.3
±
at
second
biphas-
increasing
14.1
first
NBT reduction, In contrast, the
‘I)
C.)
the
and the contamination.
response
chemiluminescence
Fig 2. response the mean
that
and 3B).
lism
4)
of
experiments)
02 consumption chalasin B (Fig
chemiluminescence
test
shows
was
by a slowly
a maximum
neutrophil
eosinophil
to fMLP
followed
nine
increased
increasing
The
response
was of
chemiluminescence
B could NBT
The
ic; an initial
nescence
N eutrophils
responded cence that of
j.tg/
Fig 3. Lucigenin-enhanced chemiluminescence. (A) fMLP (2 mol/L) was added at time 0 to eosinophils (--). neutrophils (-) and a 1 :1 mixture of eosinophils and neutrophils (. . ). (B) fMLP (2 smol/L) was added to the cells preincubated with cytochalasin B (10 sg/mL). The purity of the eosinophils and neutrophils was 95% and 96%, respectively.
neutrophils
human
concentrations of the cells with with
as
concentra-
neutrophils
of normal
stimulation
Similar concentra-
of neutrophils
eosinophils
response
maximal
PBS.
Higher
stimulated
of
and neutrophils to increasing shown in Fig 2. Pretreatment (10
with
the suboptimal
with
of fMLP)
than
as a higher
for the stimulation
experiments
solvent
reduction.
NBT mL),
with
eosinophils:
in our (the
as well
pretreated
are needed
with
DMSO
lag time cells
75
±
(Fig in free
6 nmol/L
7), respectively addition of l0
concentration I mol/L.
a very rapid to a value
in neutroIn eosinophils, increase of 297
in the ± 23
= 9). This response was transient were stimulated with I0 mol/L
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
YAZDANBAKHSH
382
two
50C
A
aC a 0
methods
response was
to ionomycin
assessed
(Fig
or
platelet-
SB, C).
DISCUSSION report
we have
shown
that
normal
phils
respond to the chemotactic increase in free intracellular calcium,
100
NBT IMLP
(10’M)
30s
reduction,
shown
Fig 4. A representative experiment showing the effect of fMLP (10 mol/L) concentrations of (A) neutrophils and values, see the text).
from a series of nine on intracellular free Ca’ (B) eosinophils (for Ca2
that
and these
with
fMLP
augmented
the
response
to fMLP Despite
burst
these
fMLP,
cells
intracellular Comparison
with
no
eosinophils eosinophils
Normal
compared
purified described
with
the
in the
level
of free
than
free
calcium
the response free
Ca2
and
1 13
was
levels
addition
were
79
fMLP
to
experiments,
addition normal
of fMLP, eosinophils
nmol/L
above
ments).
In contrast,
the
The
our
method
same
donors
parameter
resting
blood
±
SEM
significant).
(mean
±
of After
concentration by 205
SEM
isolated
for
after
after
contaminating
five
arations
the
fMLP
of five
experi-
fMLP
treat-
significant
An example difference
is shown
between
A
in Fig 5A.
the eosinophils
There isolated
B
was
20%
of
neutrophils.
the
However, the large
evidence
the
that
the
neutrophils with
that
a purity was
These
eosinophils
results
were
could
found
to
be
from the priming experiments majority of the eosinophils can
intracellular
to I08
intracellular
free
seen
exhibited
of the response
shown mol/L
Ca2,
maximally
responses is as follows:
98%
50%
of the experiments respond to 108
in 48
for
to fMLP.
The
±
that
mol/L),
respond
ment ofblood had lost their ability to respond to fMLP (I0_6 mol/L): the increase in the intracellular free Ca2 was only 27 ± I 3 nmol/L above resting values (mean ± SEM of five experiments).
with
formazan-positive. we conclude that
eosinophils
purified
(mean
not
(l0
as
intracellular
in normal
whole
levels
response
from
eosinophils
eosinophils
concentrations
eosinophil
suggest the presence of lower numbers of fMLP receptors on the eosinophil surface. In the NBT reduction test with fMLP
the intracellular Ca2 increased significantly
resting
higher
optimal
of
lower
by
in the difference
as that was
isolated
6 nmol/L
±
for an
as high to fMLP
In addition,
required
reduction tests. to exhibit an
compared
as a sensitive
of stimuli.
12 nmol/L
of
of neutrophils. were
is twice
response
B
neutrophils
by two different
of whole blood with fMLP Gallin.3 The change in intracellu-
measured
to a number ±
that
and
of NBT eosinophils
that
after
Cytochalasin
isolated
eosinophils
after treatment by Roberts and
paired
increase
PMA maximal
an
we have
enzymes
eosinophils
consumption of normal
their
of fMLP
between
procedures.
were
showed
Ca2t
granule mol/L).’7
of both
eosino-
fMLP by consumption,
Recently,
release x l0_6
(2
in the 02 the capacity
oxidative
also
human
peptide oxygen
chemiluminescence.
cells
treatment
neutrophils,’7
lar
the
(PAF)
200
In this 0
when factor
activating
ET AL
whereas mol/L Ca2
in Fig fMLP
concentrations
not
to
prep-
seen
(one did not in free
responded no further was
to
by neutrophils
I ). (b) Eosinophils with an increase (ie,
due
Eosinophil
an 02 consumption seen
neutrophils fMLP
were
(a)
already increase upon
in
stimu-
lation with I0_6 mol/L fMLP). Thus, the lack ofresponse of the eosinophil suspensions to 10_8 mol/L fMLP proves that the contamination with neutrophils was negligible. (c) Cyto-
no
chalasin
by the
B inhibited
the
eosinophil
chemiluminescence
in
1mm
CJ\%
1000
500
100
fMLP
ionomycm
(1pM)
(1pM)
PAF
(1pM)
C + C’1
0
0
0 Cl) 0
C
B
A
C.)
1000 500
>.
0 100
tt
IMLP
ionomycin
(1pM)
(1pM)
lonomycin
(1pM)
PAF
(1pM)
Fig 5. Intracellular free Ca’ concentrations in eosinophils isolated by our method (top panel) and by the method described by Roberts and Gallin3 (bottom panel) (see Materials and Methods). Effects are shown of the addition of (A) fMLP (10’ mol/L). representative of five experiments (for Ca’ values, see the text); (B) ionomycin (10-’ mol/L). representative of five experiments (in normal eosinophils. the intracellular free Ca’ level increased to 590 ± 40 nmol/L as compared with 670 ± 160 nmol/L in eosinophils purified by the method described by Roberts and GaIlin3; mean ± SEM of five experiments); and (C) PAF (10’ mol/L). representative of two experiments (the free intracellular Ca2 increased to 354 nmol/L and 352 nmol/L in normal eosinophils and eosinophils isolated with fMLP,3 respectively; mean of two experiments).
From bloodjournal.hematologylibrary.org by guest on July 10, 2011. For personal use only.
EOSINOPHIL
RESPONSE
response
to
Thus,
fMLP
the
while
(Fig
3).
(d)
The
kinetics
response
kinetics
of
the
reduction
test
examined,
eosinophils
neutrophil
where
were
seen
In addition,
laboratory
has
that
were
able
completely
in the
ruled
out.
induces
an increase
without
an appreciable
very
pure
respond
separation presume
of
therefore,
after
phils
still
can
that
free
as our
of
eosinophils
and
Ca2
possibility Gallin3
eosinophils treatment be called
from do not
a
neutrophils. respond with Our
The to fMLP fMLP,
results
the
of
not
fMLP
stimulate
the
to a subsequent et al7 and this
we
be accounted
PAF
was
by the
normal.
of Roberts
(with
inability
to
latter
to purify
to ionomycine
we have
isolated
Gallin3
from
and
had
due of the
response
In addition,
method donors purified
donors
their
was
eosinoblood
response
for by our
because
This
normal
presumably
altered
of
human
blood.
fMLP-treated
fMLP,
donor
method that
unlike
from This
same
the
to whole
that, to
the by
evidence
added
respond
successfully
or
obtained
obtained to
from
method
observation
cannot
cells
nonselected eosinophils
eosinorandom,
with similar results to those obtained with by the same method from our selected
3%
to
8%
eosinophils
in
their
peripheral
blood).
authors
In conclusion,
that,
fMLP,
eosino-
contradict
do
can
An impor-
concentrations
eosinophils our
desensitization.’8
phils
and
low
to fMLP
the
ability
receptor
and
the
very
where either
respond
the
still
facilitating
at
eosinophils
mol/L.
cells are primed to respond of another stimulus (Shaw
the eosinophils
lost
these
purification
human l0
in themselves
Gallin,3
from
eosinophils
fMLP (lO_6 mol/L) induced a decrease thus
of blood normal.
can
even
by
and
deduced
that
unlikely.
reported
of the neutrophils,
eosinophils
fMLP
findings
isolated
phils,
be
normal
study).
eosinophils
in eosinophils
highly
eosinophils in which blood. This treatment
gravity
that
observation
as well
Roberts
in the specific
cannot
that
which these dose
Roberts
that
stimulated
is that
In experiments
P. Venge,
neutrophils
show
at concentrations
mol/L),
were
gradient
possibility
lag time this
in
of eosinophils the
preparations
eosinophils, suboptimal
in a granulo-
in intracellular
render
method for human was added to whole
The
NBT
in another
H#{226}kansson and 1986).
activation
However,
(>98%)
to fMLP
Recently,
(L.
March
point
(I0’
are
and
to fMLP
tant
NBT
out
opinion
respond
from cells
to reduce
present
by contaminating
result
the
in a chemotatic
to fMLP
secreted fMLP
In
carried
eosinophils
communication,
products
(e) identifiable
work
latter to
fMLP-induced is different
to be able
visualized
to respond
personal with
and
is due
response.
to fMLP. preparation
neutrophils.
of the
morphologically
shown
of
response
of eosinophils
response cyte
that
B-inhibitable
chemiluminescence the
augmenting
cytochalasin
eosinophils
383
TO FMLP
and
normal
therefore
use of fMLP
human
any
will yield
eosinophils
isolation
altered
method
do that
respond involves
to the
eosinophils.
the REFERENCES
I. Bass DA, Grover WH, Lewis JC, Szejda P: Comparison of human eosinophils and neutrophils from normals and patients with eosinophilia. i Clin Invest 66:1265, 1980 2. Pincus SH, Schooley WR, DiNapoli AM, Broder 5: Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood 58:1 175, 1981 3. Roberts RL, Gallin il: Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils. Blood 65:433, 1985 4. Palmblad i, Gyllenhammar H, Lindgren JA, Malmston Cl.: Effects of leukotrienes andfmet-Ieu-phe on oxidative metabolism of neutrophils
and
eosinophils.
J lmmunol
132:3041,
1984
Kay AB, Walsh GM: Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils. Clin Exp Immunol 57:729, I 984 5.
6. Owen RA, Austen eosinophils.
WF, Soberman Ri, Yoshimoto T, Shefl’er AL, Lewis KF: Synthesis and release of leukotriene C4 by human i Immunol 138:532, 1987
7. Shaw Ri, Walsh GM, Cromwell 0, Moqbel R, Spry CJF, Kay AB: Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature 316:150, 1985 8. Roos D, Loos iA: Changes in the carbohydrate metabolism of stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta 222:565, 1970 mitogenically
9. Weening RS, Roos D, Loos JA: Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: A comparative study. i Lab Clin Med 83:570, 1974 10. Meerhof
Li,
Roos
D: Heterogeneity
in chronic
granuloma-
tous
disease
detected
test.
J Leuk
Biol
with
39:699,
an
improved
nitroblue
tetrazolium
slide
1986
I I . Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2 indicators with greatly improved fluorescence properties. J Biol Chem 260:3440, 1985 12. Hesketh TR, Smith GA, Moore iP, Taylor MV, Metcalve iC: Free cytoplasmic calcium concentrations and the mitogenic stimulation oflymphocytes. i Biol Chem 258:4876, 1983 13. Pozzan T, Lew DP, Wollheim CB, Tsien RY: Is cytosolic ionized calcium regulating neutrophil activation? Science 22 1: I 413, I983 I 4. Gennaro R, Pozzan T, Romeo D: Monitoring of cytosolic free Ca2 in C5a-stimulated neutrophils: Loss of receptor-modulated Ca2 stores and Ca2 uptake in granule-free cytoplasts. Proc NatI Acad
Sci
USA
81:1416,
1984
I 5. Lehmeyer JE, Snyderman R, Johnston RB ir: Stimulation of neutrophil oxidative metabolism by chemotactic peptides: Influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. Blood 54:35, 1979 16. Cohen HJ, Chovaniec ME: Superoxide generation by digitonm-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system. J Clin Invest 6 1: I 08 1 , I 978 17. Yazdanbakhsh M, Eckmann CM, de Boer M, Roos D: Purification of eosinophils from normal human blood. preparation of eosinoplasts and characterization of their functional response to various stimuli. Immunology 60:123, 1987 18. Seligmann BE, Fletcher MP, Gallin JI: Adaptation of human neutrophil
responsiveness
nyl phenylalanine.
to the
J Biol Chem
chemoattractant
257:6280,
1982
N-formylmethio-
Lihat lebih banyak...
Comentários